Abstract:Abstract Objectives Monitoring quality control for a laboratory or network with multiple instruments measuring the same analyte is challenging. We present a retrospective assessment of a method to detect medically significant out-of-control error conditions across a group of instruments measuring the same analyte. The purpose of the model was to ensure that results from any of several instruments measuring the same analytes in a laboratory or a network of laboratories provide comparable results and reduce patient risk. Limited literature has described how to manage QC in these very common situations. Methods Single Levey–Jennings control charts were designed using peer group target mean and control limits for five common clinical chemistry analytes in a network of eight analyzers in two different geographical sites. The QC rules used were 1 3s /2 2s /R 4s , with the mean being a peer group mean derived from a large population of the same instrument and the same QC batch mean and a group CV. The peer group data used to set the target means and limits were from a quality assurance program supplied by the instrument supplier. Both statistical and clinical assessments of significance were used to evaluate QC failure. Instrument bias was continually monitored. Results It was demonstrated that the biases of each instrument were not statistically or clinically different compared to the peer group’s average over six months from February 2023 until July 2023. Over this period, the error rate determined by the QC model was consistent with statistical expectations for the 1 3s /2 2s /R 4s rule. There were no external quality assurance failures, and no detected error exceeded the TEa (medical impact). Thus, the combined statistical/clinical assessment reduced unnecessary recalibrations and the need to amend results. Conclusions This paper describes the successful implementation of a quality control model for monitoring a network of instruments, measuring the same analytes and using externally provided quality control targets. The model continually assesses individual instrument bias and imprecision while ensuring all instruments in the network meet clinical goals for quality. The focus of this approach is on detecting medically significant out-of-control error conditions.

Quality Control Testing of Dose Calibrators

The effect of tube quality on externally calibrated quantitative nuclear magnetic resonance analysis: How bad can it be?

Validation of Tritium Calibration Curve in CIEMAT/NIST Activity Measurement Using Non Linear Least Squared Fittings and Calculations of the Half-Life and Decay Constant of Potassium-40

[Morning-glory papilla and detachment of the macular neuroepithelium].

Sensitivity Analysis of calibration methods and factors effecting the statistical nature of radiation measurement

Practical Considerations of Applying Traceability Concepts to the Internal Quality Control Materials for Trueness Verification in Medical Laboratories

Quality Control in Clinical Biochemistry Laboratory-A Glance

Overview and current challenges at the Calibration Laboratory of the Paul Scherrer Institute

The Impact of Dose Calibration Point Differences Between the Treatment Plan and Patient-specific Quality Assurance in Passive Scattering Proton Beam Therapy

Uncertainty evaluation of non-invasive multi-parameter detector measurements in quality assurance of diagnostic radiology

A model for managing quality control for a network of clinical chemistry instruments measuring the same analyte

The role of analytical performance specifications in international guidelines and standards dealing with metrological traceability in laboratory medicine

Dose Calibration of Health Canada's Fixed Point Surveillance System for Environmental Radiation Monitoring in Terms of Air Kerma and H*(10)

Monte Carlo evaluation of uncertainties in photon and electron TG‐51 absorbed dose calibration

Feasibility of using a transmission ion chamber for QA tests of medical linear accelerators

Developing and Using International Standards for Neutron Ambient Dose Equivalent Rate Meters

Impact of Calibration of pipette on Quality Control Results

QM and QC Testing of CT Scanners

A New Apparatus for On-Site Calibration of Gamma Dose Rate Monitors

Dosimetric verification of annual quality assurance for a linear accelerator using a transmission type detector

Comment on "Quantum color transparency"